✦ LIBER ✦

Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions

✍ Scribed by E. Karvouni; D.G. Katritsis; J.P.A. Ioannidis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of intravenous glycoprotein IIb/I

✍ F. Aslam 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Effect of intravenous glycoprotein IIb/I

✍ F Aslam 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Assessment of use of Glycoprotein IIb/II

✍ K.J. Shah*; K.H. Parikh; M.C. Chag; U.G. Shah; A.H. Chandarana; H.A. Baxi; A.M. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Glycoprotein IIb/IIIa Antagonists in the

✍ UMESH K. ARORA; IAN CONDE; NEAL S. KLEIMAN 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 893 KB

Glycoprotein IIb/IIIa inhibitor therapy

✍ Robert I. Tepper; Nancy Simonian 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Trials of platelet glycoprotein IIb/IIIa

✍ A.Michael Lincoff 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 99 KB